Search research articles
Contact Us
Filters
Showing results (521-530 of 749) with videos related to
Page
of 75
Sort By:
Oncology Reports
|
March 6, 2010
Promotion of melanoma growth by the metabolic hormone leptin
Julie A Ellerhorst, A H Diwan, Shyam M Dang, et al.
JSES International
|
June 2, 2023
The pathoanatomy of atraumatic partial distal biceps tears: a cadaveric study
Joshua D Dworkin, Christopher C Schmidt, Sean P Cooke, et al.
International Journal of Cardiology
|
August 17, 2019
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease
Rushi V Parikh, Vedant Pargaonkar, Robyn L Ball, et al.
Circulation
|
July 5, 2013
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine
Yohannes T Ghebremariam, Paea LePendu, Jerry C Lee, et al.
Biomaterials
|
January 30, 2013
Spatial patterning of endothelium modulates cell morphology, adhesiveness and transcriptional signature
Ngan F Huang, Edwina S Lai, Alexandre J S Ribeiro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 15, 2000
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans
J R Chan, R H Böger, S M Bode-Böger, et al.
The Journal of Cell Biology
|
January 14, 2009
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways
Vinicio A de Jesus Perez, Tero-Pekka Alastalo, Jenny C Wu, et al.
Circulation Research
|
February 3, 2007
Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia
Alexandra Aicher, Markus Rentsch, Ken-ichiro Sasaki, et al.
Vascular Medicine (London, England)
|
May 21, 2010
Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
Andrew M Wilson, David S Shin, Carlton Weatherby, et al.
Circulation
|
April 12, 2000
Is asymmetric dimethylarginine a novel marker of atherosclerosis?
R H Böger, S M Bode-Böger, H Matsuoka, et al.
Page
of 75
Search research articles
Search
Showing results (521-530 of 749) with videos related to
Sort By:
Page
of 75
Oncology Reports
|
March 6, 2010
Promotion of melanoma growth by the metabolic hormone leptin
Julie A Ellerhorst, A H Diwan, Shyam M Dang, et al.
JSES International
|
June 2, 2023
The pathoanatomy of atraumatic partial distal biceps tears: a cadaveric study
Joshua D Dworkin, Christopher C Schmidt, Sean P Cooke, et al.
International Journal of Cardiology
|
August 17, 2019
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease
Rushi V Parikh, Vedant Pargaonkar, Robyn L Ball, et al.
Circulation
|
July 5, 2013
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine
Yohannes T Ghebremariam, Paea LePendu, Jerry C Lee, et al.
Biomaterials
|
January 30, 2013
Spatial patterning of endothelium modulates cell morphology, adhesiveness and transcriptional signature
Ngan F Huang, Edwina S Lai, Alexandre J S Ribeiro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 15, 2000
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans
J R Chan, R H Böger, S M Bode-Böger, et al.
The Journal of Cell Biology
|
January 14, 2009
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways
Vinicio A de Jesus Perez, Tero-Pekka Alastalo, Jenny C Wu, et al.
Circulation Research
|
February 3, 2007
Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia
Alexandra Aicher, Markus Rentsch, Ken-ichiro Sasaki, et al.
Vascular Medicine (London, England)
|
May 21, 2010
Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
Andrew M Wilson, David S Shin, Carlton Weatherby, et al.
Circulation
|
April 12, 2000
Is asymmetric dimethylarginine a novel marker of atherosclerosis?
R H Böger, S M Bode-Böger, H Matsuoka, et al.
Page
of 75